Aurobindo Pharma Ltd, India's fourth-largest drugmaker by sales, said higher sales in the US and emerging markets helped its fourth-quarter net profit grow 40 per cent, above estimates, sending shares up as much as 4 per cent. Net profit for the January-March quarter rose to Rs 5.63 billion ($83.9 million) from Rs 4.03 billion a year earlier, Aurobindo said in a statement late on Monday. Analysts had forecast profit of Rs 5.55 billion, according to an average of nine estimates polled by Thomson Reuters. The company's shares rose as much as 4 per cent to Rs 786.80 in early ...
Aurobindo Pharma Q4 profit jumps 40%; shares rise 4%
Net profit for the January-March quarter rose to Rs 5.63 billion from Rs 4.03 billion a year earlier
A suggestion: you could search for this headline on the Source.
First Published: Tue, May 31 2016. 12:05 IST
Notice: Undefined property: stdClass::$canonicalUrl in /usr2/unibs/application/modules/article/controllers/ManagerController.php on line 449